Hello and Welcome to Patientsville.com, Your Source for all GLUCOVANCE information. We are dedicated to provide You with GLUCOVANCE safety information. Learn about GLUCOVANCE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
GLUCOVANCE Safety Reports
Total GLUCOVANCE reports: 92.GLUCOVANCE FDA safety alerts: No.
Reported deaths: 12 Reported hospitalizations: 23.
Take GLUCOVANCE Side Effects Survey or Share Your GLUCOVANCE Story. Read More Here.
Showing 1-75 of 92 Next >
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on Dec 08, 2006. Female patient, 63 years of age, weighting 213.8 lb, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: chills, diarrhoea, eructation, nausea, vomiting, weight decreased. GLUCOVANCE dosage: unknown. During the same period patient was treated with BYETTA, AVANDAMET. Patient recovered.GLUCOVANCE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2006. Male patient, 67 years of age, was diagnosed with diabetes mellitus, weight decreased, type 2 diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anorexia, blood glucose decreased, blood glucose increased, nausea. GLUCOVANCE dosage: unknown. During the same period patient was treated with BYETTA, ACCURETIC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on Jan 22, 2007. Male patient was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. GLUCOVANCE dosage: 5/500MG.. During the same period patient was treated with PLAVIX. Patient recovered.
GLUCOVANCE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 58 years of age, weighting 218.3 lb, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: headache, nausea, pharyngolaryngeal pain, sinus congestion, vomiting. GLUCOVANCE dosage: unknown. During the same period patient was treated with SYNTHROID, LIPITOR, CYMBALTA, DIOVAN HCT. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on Mar 13, 2007. Female patient, 69 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: throat irritation. GLUCOVANCE dosage: 5MG/500MG, 2 TABLETS IN THE AM AND 2 TABLETS IN THE PM.. During the same period patient was treated with LOTREL, COREG, PLAVIX, DIGESTIVE ENZYMES, VITAMIN, MINERAL, CALCIUM CHLORIDE. Patient recovered.
GLUCOVANCE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Female patient, 67 years of age, weighting 220.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: rash. GLUCOVANCE dosage: unknown. During the same period patient was treated with BYETTA, MOBIC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on Apr 09, 2007. Male patient, 57 years of age, weighting 260.1 lb, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, international normalised ratio decreased. GLUCOVANCE dosage: unknown. During the same period patient was treated with BETAPACE, AVALIDE, TRICOR, DIGITEK, POTASSIUM SUPPLEMENTS, ACTOS, NORVASC. Patient recovered.
GLUCOVANCE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Female patient, 83 years of age, weighting 200.6 lb, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, somnolence. GLUCOVANCE dosage: unknown. During the same period patient was treated with LOPRESSOR, LASIX, COUMADIN, PRINIVIL, ZOCOR. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on Apr 24, 2007. Male patient, 70 years of age, weighting 194.0 lb, was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. GLUCOVANCE dosage: unknown. During the same period patient was treated with LISINOPRIL, LOVASTATIN, CEPHALEXIN, ALBUTEROL, ASCORBIC ACID. Patient recovered.
GLUCOVANCE problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Female patient, 78 years of age, weighting 134.5 lb, was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. GLUCOVANCE dosage: unknown. During the same period patient was treated with ACTOS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on May 31, 2007. Female patient, 45 years of age, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypoglycaemia. GLUCOVANCE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, JANUVIA, AMARYL, VYTORIN, ACTOS. Patient recovered.
GLUCOVANCE problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, weighting 134.5 lb, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: burning sensation, hypoaesthesia. GLUCOVANCE dosage: unknown. During the same period patient was treated with LISINOPRIL, ASPIRIN, CENTRUM. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on June 26, 2007. Male patient, weighting 220.5 lb, was diagnosed with diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. GLUCOVANCE dosage: unknown. Patient recovered.
GLUCOVANCE problem was reported by a Physician from UNITED STATES on Aug 16, 2007. Female patient was diagnosed with type 2 diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: glycosylated haemoglobin increased. GLUCOVANCE dosage: unknown. Patient recovered.
Consumer or non-health professional from FRANCE reported GLUCOVANCE problem on Sept 20, 2007. Female patient, 73 years of age, was diagnosed with blood potassium abnormal, hypertension and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hypokalaemia, malaise. GLUCOVANCE dosage: unknown. During the same period patient was treated with IPERTEN, INIPOMP, ANAFRANIL, KALEORID, COTAREG. Patient was hospitalized. Patient recovered.
GLUCOVANCE problem was reported by a Physician from UNITED STATES on Sept 24, 2007. Female patient, 62 years of age, was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatocellular damage. GLUCOVANCE dosage: unknown. During the same period patient was treated with LIPITOR, CENTRUM VITAMINS, ALEVE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLUCOVANCE problem on Sept 20, 2007. Female patient, 41 years of age, was diagnosed with type 2 diabetes mellitus and was treated with GLUCOVANCE. After drug was administered, patient experienced the following problems/side effects: injection site rash, loss of consciousness. GLUCOVANCE dosage: unknown. During the same period patient was treated with LANTUS, BYETTA. Patient recovered.
Showing 1-75 of 92 Next >